TapewireFind a company

person · Reporting owner

GOLD STEPHEN J

Disclosed activity across 3 companies

Tapewire entity
16212
SEC CIK
0001252005

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CVS HEALTH CorpCVS · Entity 2884EVP & CIOApril 01, 2017April 04, 2017
WORLD KINECT CORPINT · Entity 4582DirectorMay 24, 2019May 29, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CVS HEALTH Corp

Report date April 01, 2017 · Filed April 04, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect29,187.6785 Reported balance After 2017-04-01 transaction · row 1
1 source row

Row 1 · 2017-04-01 · Tax withholding · Disposed 1,396 · Balance 29,187.6785

F1: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award.

Common Stock (restricted)SEC Table I · non-derivativeDirect46,818 Reported balance After 2017-04-03 transaction · row 2
1 source row

Row 2 · 2017-04-03 · Grant · Acquired 8,648 · Balance 46,818

F2: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022.

Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03Direct67,621 Reported balance After 2017-04-03 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2017-04-03 · Grant · Acquired 67,621 · Balance 67,621

F3: Option becomes exercisable in four equal annual installments, commencing 4/3/2018.

Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.53 · Expires 2020-04-01Direct25,571 Reported balance Holding disclosure · report date 2017-04-01 · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · Balance 25,571

F4: Option became exercisable in four equal annual installments, commencing 4/1/2014.

Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.29 · Expires 2021-04-01Direct33,569 Reported balance Holding disclosure · report date 2017-04-01 · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · Balance 33,569

F5: Option became exercisable in four equal annual installments, commencing 4/1/2015.

Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $47.29 · Expires 2022-07-09Direct63,440 Reported balance Holding disclosure · report date 2017-04-01 · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · Balance 63,440

F6: Option became exercisable in three equal annual installments, commencing 07/09/2015.

Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $102.26 · Expires 2022-04-01Direct41,089 Reported balance Holding disclosure · report date 2017-04-01 · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · Balance 41,089

F7: Option became exercisable in four equal annual installments, commencing 4/1/2016.

Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01Direct48,395 Reported balance Holding disclosure · report date 2017-04-01 · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · Balance 48,395

F8: Option became exercisable in four equal annual installments, commencing 4/1/2017.

Common Stock (pep)SEC Table I · non-derivativeDirect10,265.9554 Reported balance Holding disclosure · report date 2017-04-01 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 10,265.9554

Stock UnitSEC Table I · non-derivativeDirect7,240.8004 Reported balance Holding disclosure · report date 2017-04-01 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 7,240.8004

Filing footnotes · ownership attribution and instrument terms

F1: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award.

F2: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022.

F3: Option becomes exercisable in four equal annual installments, commencing 4/3/2018.

F4: Option became exercisable in four equal annual installments, commencing 4/1/2014.

F5: Option became exercisable in four equal annual installments, commencing 4/1/2015.

F6: Option became exercisable in three equal annual installments, commencing 07/09/2015.

F7: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F8: Option became exercisable in four equal annual installments, commencing 4/1/2017.

WORLD KINECT CORP

Report date May 24, 2019 · Filed May 29, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect15,487 Reported balance After 2019-05-24 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2019-05-24 · Grant · Acquired 5,321 · Balance 15,487

F1: These shares were issued as a restricted stock unit grant to the reporting person by the issuer under the issuer's 2016 Omnibus Plan.

F2: The restricted stock units shall vest on the earlier of: (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: These shares were issued as a restricted stock unit grant to the reporting person by the issuer under the issuer's 2016 Omnibus Plan.

F2: The restricted stock units shall vest on the earlier of: (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

VERINT SYSTEMS INC

Report date November 26, 2025 · Filed November 26, 2025

Section 16 reporting ended · disclosed 2025-11-26. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2025-11-26 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2025-11-26 · Disposition to issuer · Disposed 28,473 · Balance 0

F1: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of August 24, 2025, by and among Verint Systems Inc. ("Verint"), Calabrio, Inc. ("Parent"), and Viking Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into Verint, with Verint surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each share of Verint's common stock, par value $0.001 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $20.50 in cash without interest (the "Merger Consideration").

Common StockSEC Table I · non-derivativeDirect8,980 Reported balance After 2025-11-26 transaction · row 2 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 2 · 2025-11-26 · Exercise / conversion · Acquired 8,980 · Balance 8,980

F2: Reflects vested restricted stock units ("RSUs") further described in footnote three below.

F1: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of August 24, 2025, by and among Verint Systems Inc. ("Verint"), Calabrio, Inc. ("Parent"), and Viking Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into Verint, with Verint surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each share of Verint's common stock, par value $0.001 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $20.50 in cash without interest (the "Merger Consideration").

F3: Each RSU represents a right to receive one share of common stock of Verint and/or cash upon vesting. Pursuant to the Merger Agreement, each RSU became fully vested and entitled to the Merger Consideration as of the Effective Time.

Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2025-11-26 transaction · row 3 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 3 · 2025-11-26 · Disposition to issuer · Disposed 8,980 · Balance 0

F2: Reflects vested restricted stock units ("RSUs") further described in footnote three below.

F1: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of August 24, 2025, by and among Verint Systems Inc. ("Verint"), Calabrio, Inc. ("Parent"), and Viking Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into Verint, with Verint surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each share of Verint's common stock, par value $0.001 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $20.50 in cash without interest (the "Merger Consideration").

F3: Each RSU represents a right to receive one share of common stock of Verint and/or cash upon vesting. Pursuant to the Merger Agreement, each RSU became fully vested and entitled to the Merger Consideration as of the Effective Time.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2025-11-26 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2025-11-26 · Exercise / conversion · Disposed 8,980 · Balance 0

F3: Each RSU represents a right to receive one share of common stock of Verint and/or cash upon vesting. Pursuant to the Merger Agreement, each RSU became fully vested and entitled to the Merger Consideration as of the Effective Time.

F1: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of August 24, 2025, by and among Verint Systems Inc. ("Verint"), Calabrio, Inc. ("Parent"), and Viking Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into Verint, with Verint surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each share of Verint's common stock, par value $0.001 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $20.50 in cash without interest (the "Merger Consideration").

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of August 24, 2025, by and among Verint Systems Inc. ("Verint"), Calabrio, Inc. ("Parent"), and Viking Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into Verint, with Verint surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each share of Verint's common stock, par value $0.001 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $20.50 in cash without interest (the "Merger Consideration").

F2: Reflects vested restricted stock units ("RSUs") further described in footnote three below.

F3: Each RSU represents a right to receive one share of common stock of Verint and/or cash upon vesting. Pursuant to the Merger Agreement, each RSU became fully vested and entitled to the Merger Consideration as of the Effective Time.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 26, 2025 Filed Nov 26, 2025 11:56 UTC VERINT SYSTEMS INC VRNT · Entity 72443 Exercise / conversionRestricted Stock Units · Derivative 8,980 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-299233 · ownership.xml · derivative · entry 4

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,980 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a right to receive one share of common stock of Verint and/or cash upon vesting. Pursuant to the Merger Agreement, each RSU became fully vested and entitled to the Merger Consideration as of the Effective Time.

F1 · price: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of August 24, 2025, by and among Verint Systems Inc. ("Verint"), Calabrio, Inc. ("Parent"), and Viking Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into Verint, with Verint surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each share of Verint's common stock, par value $0.001 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $20.50 in cash without interest (the "Merger Consideration").

F3 · price: Each RSU represents a right to receive one share of common stock of Verint and/or cash upon vesting. Pursuant to the Merger Agreement, each RSU became fully vested and entitled to the Merger Consideration as of the Effective Time.

F3 · derivative.expiration_date: Each RSU represents a right to receive one share of common stock of Verint and/or cash upon vesting. Pursuant to the Merger Agreement, each RSU became fully vested and entitled to the Merger Consideration as of the Effective Time.

Read SEC document
November 26, 2025 Filed Nov 26, 2025 11:56 UTC VERINT SYSTEMS INC VRNT · Entity 72443 Disposition to issuerCommon Stock 8,980 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-299233 · ownership.xml · nonDerivative · entry 3

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · security: Reflects vested restricted stock units ("RSUs") further described in footnote three below.

F1 · price: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of August 24, 2025, by and among Verint Systems Inc. ("Verint"), Calabrio, Inc. ("Parent"), and Viking Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into Verint, with Verint surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each share of Verint's common stock, par value $0.001 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $20.50 in cash without interest (the "Merger Consideration").

F3 · price: Each RSU represents a right to receive one share of common stock of Verint and/or cash upon vesting. Pursuant to the Merger Agreement, each RSU became fully vested and entitled to the Merger Consideration as of the Effective Time.

Read SEC document
November 26, 2025 Filed Nov 26, 2025 11:56 UTC VERINT SYSTEMS INC VRNT · Entity 72443 Exercise / conversionCommon Stock 8,980 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-299233 · ownership.xml · nonDerivative · entry 2

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Reflects vested restricted stock units ("RSUs") further described in footnote three below.

F1 · price: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of August 24, 2025, by and among Verint Systems Inc. ("Verint"), Calabrio, Inc. ("Parent"), and Viking Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into Verint, with Verint surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each share of Verint's common stock, par value $0.001 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $20.50 in cash without interest (the "Merger Consideration").

F3 · price: Each RSU represents a right to receive one share of common stock of Verint and/or cash upon vesting. Pursuant to the Merger Agreement, each RSU became fully vested and entitled to the Merger Consideration as of the Effective Time.

Read SEC document
November 26, 2025 Filed Nov 26, 2025 11:56 UTC VERINT SYSTEMS INC VRNT · Entity 72443 Disposition to issuerCommon Stock 28,473 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-299233 · ownership.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of August 24, 2025, by and among Verint Systems Inc. ("Verint"), Calabrio, Inc. ("Parent"), and Viking Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into Verint, with Verint surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each share of Verint's common stock, par value $0.001 per share, that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive $20.50 in cash without interest (the "Merger Consideration").

Read SEC document
April 22, 2025 Filed Apr 24, 2025 16:31 UTC VERINT SYSTEMS INC VRNT · Entity 72443 GrantRestricted Stock Units · Derivative 8,980 Not disclosed Not disclosed
Disclosure

SEC source: 0001166388-25-000070 · wk-form4_1745526690.xml · derivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,980

Underlying: Common Stock · 8,980 shares

Expires not disclosed

F1 · derivative.exercise_price: On April 22, 2025, the reporting person was granted 8,980 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 8,980 RSUs will vest on April 10, 2026.

F1 · deemedExecutionDate: On April 22, 2025, the reporting person was granted 8,980 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 8,980 RSUs will vest on April 10, 2026.

F1 · shares: On April 22, 2025, the reporting person was granted 8,980 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 8,980 RSUs will vest on April 10, 2026.

F1 · price: On April 22, 2025, the reporting person was granted 8,980 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 8,980 RSUs will vest on April 10, 2026.

F1 · derivative.exercise_date: On April 22, 2025, the reporting person was granted 8,980 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 8,980 RSUs will vest on April 10, 2026.

F1 · derivative.expiration_date: On April 22, 2025, the reporting person was granted 8,980 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 8,980 RSUs will vest on April 10, 2026.

Read SEC document
April 10, 2025 Filed Apr 14, 2025 16:50 UTC VERINT SYSTEMS INC VRNT · Entity 72443 Exercise / conversionRestricted Stock Units · Derivative 6,859 Not disclosed Not disclosed
Disclosure

SEC source: 0001166388-25-000040 · wk-form4_1744663846.xml · derivative · entry 4

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,859 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

F1 · shares: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

F1 · price: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

F1 · derivative.exercise_date: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

F1 · derivative.expiration_date: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

Read SEC document
April 10, 2025 Filed Apr 14, 2025 16:50 UTC VERINT SYSTEMS INC VRNT · Entity 72443 SaleCommon Stock 2,744 $16.07 $44,096.08
Disclosure

SEC source: 0001166388-25-000040 · wk-form4_1744663846.xml · nonDerivative · entry 2

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,473

F3 · shares: Amount withheld by the issuer to satisfy applicable tax withholding resulting from the vesting on April 10, 2025 of a previously disclosed award of RSUs.

F1 · price: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

F4 · price: Represents the price per share utilized by the issuer to calculate the number of shares to be withheld to satisfy the applicable tax withholding, which price was equal to the closing price of the issuer's common stock on the last trading day prior to the vesting of the related RSU award.

Read SEC document
April 10, 2025 Filed Apr 14, 2025 16:50 UTC VERINT SYSTEMS INC VRNT · Entity 72443 Exercise / conversionCommon Stock 6,859 $0.00 $0.00
Disclosure

SEC source: 0001166388-25-000040 · wk-form4_1744663846.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,217

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

F2 · balance_after: The reporting person's number of shares of common stock owned was previously overstated by 6,859 shares due to the number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 filed on April 24, 2024.

Read SEC document
April 22, 2024 Filed Apr 24, 2024 17:04 UTC VERINT SYSTEMS INC VRNT · Entity 72443 GrantCommon Stock 6,859 $0.00 $0.00
Disclosure

SEC source: 0001166388-24-000068 · wk-form4_1713992639.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,217

F1 · shares: Grant of restricted stock units vesting 100% on April 10, 2025.

Read SEC document
April 22, 2024 Filed Apr 14, 2025 16:50 UTC VERINT SYSTEMS INC VRNT · Entity 72443 GrantRestricted Stock Units · Derivative 6,859 Not disclosed Not disclosed
Disclosure

SEC source: 0001166388-25-000040 · wk-form4_1744663846.xml · derivative · entry 3

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,859

Underlying: Common Stock · 6,859 shares

Expires not disclosed

F1 · derivative.exercise_price: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

F1 · shares: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

F1 · price: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

F1 · derivative.exercise_date: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

F1 · derivative.expiration_date: On April 22, 2024, the reporting person was granted 6,859 restricted stock units ("RSUs") subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. All 6,859 RSUs vested on April 10, 2025.

F5 · balance_after: These RSUs were incorrectly disclosed in Table I on the reporting person's Form 4 filed on April 24, 2024.

Read SEC document
April 20, 2023 Filed Apr 24, 2023 16:31 UTC VERINT SYSTEMS INC VRNT · Entity 72443 GrantCommon Stock 5,274 $0.00 $0.00
Disclosure

SEC source: 0001166388-23-000064 · wf-form4_168236825244503.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,358

F1 · shares: Grant of restricted stock units vesting 100% on April 10, 2024.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 16:19 UTC VERINT SYSTEMS INC VRNT · Entity 72443 GrantCommon Stock 3,606 $0.00 $0.00
Disclosure

SEC source: 0001166388-22-000065 · wf-form4_165109076556475.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,084

F1 · shares: Grant of restricted stock units vesting 100% on April 12, 2023.

Read SEC document
April 20, 2021 Filed Apr 22, 2021 17:12 UTC VERINT SYSTEMS INC VRNT · Entity 72443 GrantCommon Stock 4,178 $0.00 $0.00
Disclosure

SEC source: 0001166388-21-000065 · wf-form4_161912594074407.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,478

F1 · shares: Grant of restricted stock units vesting 100% on April 11, 2022.

F2 · balance_after: The number of shares underlying unvested RSUs that were previously reported on Form 4 has been adjusted in connection with the closing of the spin-off of Cognyte Software Ltd. by the Issuer on February 1, 2021 and included in the total in Column 5.

Read SEC document
August 26, 2020 Filed Aug 28, 2020 16:45 UTC VERINT SYSTEMS INC VRNT · Entity 72443 GrantCommon Stock 4,326 $0.00 $0.00
Disclosure

SEC source: 0001166388-20-000098 · wf-form4_159864751658498.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,333

F1 · shares: Grant of restricted stock units vesting 100% on April 8, 2021.

Read SEC document
May 24, 2019 Filed May 29, 2019 23:03 UTC WORLD KINECT CORP INT · Entity 4582 GrantCommon Stock 5,321 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-033300 · doc4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,487

F1 · security: These shares were issued as a restricted stock unit grant to the reporting person by the issuer under the issuer's 2016 Omnibus Plan.

F2 · shares: The restricted stock units shall vest on the earlier of: (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

Read SEC document
April 19, 2019 Filed Apr 23, 2019 16:45 UTC VERINT SYSTEMS INC VRNT · Entity 72443 GrantCommon Stock 3,300 $0.00 $0.00
Disclosure

SEC source: 0001166388-19-000064 · wf-form4_155605229536591.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,007

F1 · shares: Grant of restricted stock units vesting 100% on April 6, 2020.

Read SEC document
May 24, 2018 Filed May 29, 2018 22:13 UTC WORLD KINECT CORP INT · Entity 4582 GrantCommon Stock 7,434 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-033946 · doc4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,166

F1 · security: These shares were issued as a restricted stock unit grant to the reporting person by the issuer under the issuer's 2016 Omnibus Plan.

F2 · shares: The restricted stock units shall vest on the earlier of: (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

Read SEC document
October 04, 2017 Filed Oct 4, 2017 22:32 UTC WORLD KINECT CORP INT · Entity 4582 GrantCommon Stock 2,732 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-055988 · doc4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,732

F1 · security: These shares were issued as a restricted stock unit grant to the reporting person by the issuer under the issuer's 2016 Omnibus Plan.

F2 · shares: The restricted stock units shall vest on the earlier of: (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) May 25, 2018.

Read SEC document
April 03, 2017 Filed Apr 4, 2017 21:42 UTC CVS HEALTH Corp CVS · Entity 2884 GrantStock Option · Derivative 67,621 $78.05 Strike: $78.05 $5,277,819.05
Disclosure

SEC source: 0001127602-17-014061 · form4.xml · derivative · entry 5

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,621

Underlying: Common Stock · 67,621 shares

Expires 2024-04-03

F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018.

Read SEC document
April 03, 2017 Filed Apr 4, 2017 21:42 UTC CVS HEALTH Corp CVS · Entity 2884 GrantCommon Stock (restricted) 8,648 $78.05 $674,976.40
Disclosure

SEC source: 0001127602-17-014061 · form4.xml · nonDerivative · entry 2

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,818

F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022.

Read SEC document
April 01, 2017 Filed Apr 4, 2017 21:42 UTC CVS HEALTH Corp CVS · Entity 2884 Tax withholdingCommon Stock 1,396 $78.50 $109,586.00
Disclosure

SEC source: 0001127602-17-014061 · form4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,187.6785

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award.

Read SEC document
February 28, 2017 Filed Mar 2, 2017 21:57 UTC CVS HEALTH Corp CVS · Entity 2884 Tax withholdingCommon Stock 3,462 $80.58 $278,967.96
Disclosure

SEC source: 0001127602-17-009789 · form4.xml · nonDerivative · entry 2

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,891.6785

F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2017 Filed Mar 2, 2017 21:57 UTC CVS HEALTH Corp CVS · Entity 2884 GrantCommon Stock 9,307 $80.58 $749,958.06
Disclosure

SEC source: 0001127602-17-009789 · form4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,353.6785

F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
May 05, 2016 Filed May 6, 2016 20:29 UTC CVS HEALTH Corp CVS · Entity 2884 Exercise / conversionStock Option · Derivative 9,798 $0.00 Strike: $47.29 $0.00
Disclosure

SEC source: 0001127602-16-051404 · form4.xml · derivative · entry 6

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,440

Underlying: Common Stock · 9,798 shares

Expires 2022-07-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 07/09/2015.

Read SEC document
May 05, 2016 Filed May 6, 2016 20:29 UTC CVS HEALTH Corp CVS · Entity 2884 SaleCommon Stock 9,798 $105.00 $1,028,790.00
Disclosure

SEC source: 0001127602-16-051404 · form4.xml · nonDerivative · entry 2

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,560.3558

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan.

Read SEC document
May 05, 2016 Filed May 6, 2016 20:29 UTC CVS HEALTH Corp CVS · Entity 2884 Exercise / conversionCommon Stock 9,798 $47.29 $463,347.42
Disclosure

SEC source: 0001127602-16-051404 · form4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,358.3558

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2016 Filed Apr 5, 2016 22:39 UTC CVS HEALTH Corp CVS · Entity 2884 GrantStock Option · Derivative 48,395 $104.82 Strike: $104.82 $5,072,763.90
Disclosure

SEC source: 0001127602-16-048894 · form4.xml · derivative · entry 8

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,395

Underlying: Common Stock · 48,395 shares

Expires 2023-04-01

F5 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017.

Read SEC document
April 01, 2016 Filed Apr 5, 2016 22:39 UTC CVS HEALTH Corp CVS · Entity 2884 Exercise / conversionStock Option · Derivative 21,922 $0.00 Strike: $47.29 $0.00
Disclosure

SEC source: 0001127602-16-048894 · form4.xml · derivative · entry 7

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,238

Underlying: Common Stock · 21,922 shares

Expires 2022-07-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 07/09/2015.

Read SEC document
April 01, 2016 Filed Apr 5, 2016 22:39 UTC CVS HEALTH Corp CVS · Entity 2884 GrantCommon Stock (restricted) 6,439 $104.82 $674,935.98
Disclosure

SEC source: 0001127602-16-048894 · form4.xml · nonDerivative · entry 4

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,862

F3 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021.

Read SEC document
April 01, 2016 Filed Apr 5, 2016 22:39 UTC CVS HEALTH Corp CVS · Entity 2884 Tax withholdingCommon Stock 1,546 $104.82 $162,051.72
Disclosure

SEC source: 0001127602-16-048894 · form4.xml · nonDerivative · entry 3

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,560.3558

F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award.

Read SEC document
April 01, 2016 Filed Apr 5, 2016 22:39 UTC CVS HEALTH Corp CVS · Entity 2884 SaleCommon Stock 21,922 $105.00 $2,301,810.00
Disclosure

SEC source: 0001127602-16-048894 · form4.xml · nonDerivative · entry 2

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,126.3558

F1 · kind: Sales were effected pursuant to a Rule 10b5-1 plan.

Read SEC document
April 01, 2016 Filed Apr 5, 2016 22:39 UTC CVS HEALTH Corp CVS · Entity 2884 Exercise / conversionCommon Stock 21,922 $47.29 $1,036,691.38
Disclosure

SEC source: 0001127602-16-048894 · form4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,048.3558

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 29, 2016 Filed Mar 2, 2016 22:41 UTC CVS HEALTH Corp CVS · Entity 2884 GrantCommon Stock 7,816 $97.17 $759,480.72
Disclosure

SEC source: 0001127602-16-044587 · form4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,126.3558

F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
April 01, 2015 Filed Apr 3, 2015 20:22 UTC CVS HEALTH Corp CVS · Entity 2884 GrantStock Option · Derivative 41,089 $102.26 Strike: $102.26 $4,201,761.14
Disclosure

SEC source: 0001127602-15-013940 · form4.xml · derivative · entry 5

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,089

Underlying: Common Stock · 41,089 shares

Expires 2022-04-01

F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016.

Read SEC document
April 01, 2015 Filed Apr 3, 2015 20:22 UTC CVS HEALTH Corp CVS · Entity 2884 GrantCommon Stock (restricted) 5,867 $102.26 $599,959.42
Disclosure

SEC source: 0001127602-15-013940 · form4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · EVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,403

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020.

Read SEC document
February 27, 2015 Filed Mar 3, 2015 22:25 UTC CVS HEALTH Corp CVS · Entity 2884 GrantStock Unit 6,991 $103.87 $726,155.17
Disclosure

SEC source: 0001127602-15-009666 · form4.xml · nonDerivative · entry 2

GOLD STEPHEN J · CIK 0001252005 · SVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,991

F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer.

Read SEC document
February 27, 2015 Filed Mar 3, 2015 22:25 UTC CVS HEALTH Corp CVS · Entity 2884 GrantCommon Stock 1,432 $103.87 $148,741.84
Disclosure

SEC source: 0001127602-15-009666 · form4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · SVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,905.118

F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
April 01, 2014 Filed Apr 3, 2014 20:38 UTC CVS HEALTH Corp CVS · Entity 2884 GrantStock Option · Derivative 33,569 $74.29 Strike: $74.29 $2,493,841.01
Disclosure

SEC source: 0001127602-14-014005 · form4.xml · derivative · entry 5

GOLD STEPHEN J · CIK 0001252005 · SVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,569

Underlying: Common Stock · 33,569 shares

Expires 2021-04-01

F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015.

Read SEC document
April 01, 2014 Filed Apr 3, 2014 20:38 UTC CVS HEALTH Corp CVS · Entity 2884 GrantCommon Stock (restricted) 20,191 $74.29 $1,499,989.39
Disclosure

SEC source: 0001127602-14-014005 · form4.xml · nonDerivative · entry 2

GOLD STEPHEN J · CIK 0001252005 · SVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,536

F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse on 4/1/2019.

Read SEC document
April 01, 2014 Filed Apr 3, 2014 20:38 UTC CVS HEALTH Corp CVS · Entity 2884 GrantCommon Stock (restricted) 5,384 $74.29 $399,977.36
Disclosure

SEC source: 0001127602-14-014005 · form4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · SVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,345

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019.

Read SEC document
April 01, 2013 Filed Apr 3, 2013 20:41 UTC CVS HEALTH Corp CVS · Entity 2884 GrantStock Option · Derivative 25,571 $54.53 Strike: $54.53 $1,394,386.63
Disclosure

SEC source: 0001127602-13-013287 · form4.xml · derivative · entry 4

GOLD STEPHEN J · CIK 0001252005 · SVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,571

Underlying: Common Stock · 25,571 shares

Expires 2020-04-01

F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014.

Read SEC document
April 01, 2013 Filed Apr 3, 2013 20:41 UTC CVS HEALTH Corp CVS · Entity 2884 GrantCommon Stock (restricted) 5,961 $54.53 $325,053.33
Disclosure

SEC source: 0001127602-13-013287 · form4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · SVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,961

F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018.

Read SEC document
July 09, 2012 Filed Jul 10, 2012 20:27 UTC CVS HEALTH Corp CVS · Entity 2884 GrantStock Option · Derivative 95,160 $47.29 Strike: $47.29 $4,500,116.40
Disclosure

SEC source: 0001127602-12-022041 · form4.xml · derivative · entry 3

GOLD STEPHEN J · CIK 0001252005 · SVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,160

Underlying: Common Stock · 95,160 shares

Expires 2022-07-09

F2 · derivative.exercise_date: Options become exercisable in three equal annual installments, commencing 07/09/2015.

Read SEC document
July 09, 2012 Filed Jul 10, 2012 20:27 UTC CVS HEALTH Corp CVS · Entity 2884 GrantCommon Stock (pep) 9,516 $47.29 $450,011.64
Disclosure

SEC source: 0001127602-12-022041 · form4.xml · nonDerivative · entry 2

GOLD STEPHEN J · CIK 0001252005 · SVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,516

F1 · shares: Consists of matching Restricted Stock Units awarded pursuant to Issuer's Partnership Equity Program under the 2010 Incentive Compensation Plan. Restrictions lapse on 7/9/2017.

Read SEC document
July 09, 2012 Filed Jul 10, 2012 20:27 UTC CVS HEALTH Corp CVS · Entity 2884 PurchaseCommon Stock 9,516 $47.29 $450,011.64
Disclosure

SEC source: 0001127602-12-022041 · form4.xml · nonDerivative · entry 1

GOLD STEPHEN J · CIK 0001252005 · SVP & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,516

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.